STEVEN MICKELSON: Open Payments
NPI 1477673804 · SONOMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 10 payments from 6 companies in 2025. Trend: 2023 $459 · 2024 $819 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| Amgen Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| B. Braun Interventional Systems Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: ELIQUIS, ONPATTRO, REPATHA, VYNDAQEL, CP STENT, FARXIGA, ENTRESTO, LEQVIO.
Industry payments across CA — which companies pay providers there.
